Both options are designed to support appetite control, food noise reduction, and metabolic weight management, but they differ in how they are taken, how consistently patients use them, how they fit into daily life, and how providers think about dose strategy
Its primary functions include: Stimulating Insulin Release: GLP-1 tells the pancreas to release insulin, which helps your cells absorb glucose from the bloodstream, thereby lowering blood sugar levels after a meal
Tirzepatide is an acylated peptide engineered to activate the GIP and GLP-1 receptors, key mediators of insulin secretion that are also expressed in regions of the brain that regulate food intake
This decision comes as the GLP-1 drug category continues to grow, with new treatments offering improved weight-loss results and, in some cases, reduced costs
Clinical outcomes depend on dose, adherence, and individual metabolism rather than brand versus compounded formulation
Brief overview: glucagon history and physiology
